TITLE

Did a Flawed Study Design Affect the Results of the VYTAL Study?

AUTHOR(S)
McMahon, David E.
PUB. DATE
April 2007
SOURCE
Mayo Clinic Proceedings;Apr2007, Vol. 82 Issue 4, p521
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Vytorin vs. Atorvastatin in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia."
ACCESSION #
24851328

 

Related Articles

  • Mehamudgaravati and type 2 diabetes mellitus. Tanna, Ila; Chandola, H. M.; Joshi, J. R. // AYU: An International Quarterly Journal of Research in Ayurveda;Jul-Sep2012, Vol. 32 Issue 3, p432 

    A response by Ila Tanna et al to a letter to the editor about their article "Clinical Efficacy of Mehamudgaravati in Type 2 Diabetes Mellitus" in the 2011 issue is presented.

  • Once-weekly exenatide in type 2 diabetes. Parmar, Dinesh; Jadav, Shilpa // International Journal of Diabetes in Developing Countries;Apr2011, Vol. 31 Issue 2, p121 

    A letter to the editor is presented in response to a study on the safety and efficacy of exenatide in type 2 diabetes.

  • Combination Lipid Therapy in Type 2 Diabetes. Saely, Christoph H.; Rein, Philipp; Drexel, Heinz // New England Journal of Medicine;8/12/2010, Vol. 363 Issue 7, p692 

    A letter to the editor is presented in response to an article about the combination lipid therapy in type 2 diabetes by H. N. Ginsberg and colleagues in the April 29, 2010 issue.

  • Combination Lipid Therapy in Type 2 Diabetes. Sacks, Frank M.; Carey, Vincent J.; Fruchart, Jean-Charles // New England Journal of Medicine;8/12/2010, Vol. 363 Issue 7, p692 

    A letter to the editor is presented in response to an article about the combination lipid therapy in type 2 diabetes by H. N. Ginsberg and colleagues in the April 29, 2010 issue.

  • Combination Lipid Therapy in Type 2 Diabetes. Perkins, William J. // New England Journal of Medicine;8/12/2010, Vol. 363 Issue 7, p692 

    A letter to the editor is presented in response to an article about the combination lipid therapy in type 2 diabetes by H. N. Ginsberg and colleagues in the April 29, 2010 issue.

  • Combination Lipid Therapy in Type 2 Diabetes. Ginsberg, Henry N.; Elam, Marshall B.; Lovato, Laura C. // New England Journal of Medicine;8/12/2010, Vol. 363 Issue 7, p692 

    A response by H. N. Ginsberg and colleagues to a letter to the editor about their article on the combination lipid therapy in type 2 diabetes in the April 29, 2010 issue is presented.

  • A Comment on the International Diabetic Federation Statement. Deitel, Mervyn // Obesity Surgery;Jan2012, Vol. 22 Issue 1, p188 

    A letter to the editor is presented in response to an article by Dr. Walter Pories about metabolic surgery for type 2 diabetes.

  • Insulin Combination Therapy in Type 2 Diabetes Mellitus. Hassan, Yusuf; Gupta, Gaurav; Hassan, Saira // Annals of Internal Medicine;4/20/2004, Vol. 140 Issue 8, p666 

    Presents a letter to the editor in response to the article "Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: A randomized, controlled trial," by A. Fritsche, M. A. Schweitzer, H. U....

  • Insulin Combination Therapy in Type 2 Diabetes Mellitus. Mikhail, Nasser; Wali, Soma // Annals of Internal Medicine;4/20/2004, Vol. 140 Issue 8, p666 

    Presents a letter to the editor in response to the article "Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: A randomized, controlled trial," by A. Fritsche, M. A. Schweitzer, H. U....

  • Insulin Combination Therapy in Type 2 Diabetes Mellitus. Fritsche, Andreas; Häring, Hans-Ulrich; Schweitzer, Matthias Axel // Annals of Internal Medicine;4/20/2004, Vol. 140 Issue 8, p667 

    Presents a response by Fritsche et al to letters to the editor on their article "Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes: A randomized, controlled trial," in the volume 138 of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics